Drug-eluting stent

• US 7,951,193 B2
• Filed: 07/23/2008
• Issued: 05/31/2011
• Est. Priority Date: 07/23/2008
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Davis, Liza, Robertson, Kim, Hitzman, Cory, Robaina, Samuel, Lenz, Jason T.
• Primary Examiner(s): McDermott; Corrine M
• Assistant Examiner(s): MATHEW, SEEMA
• Application Number:
  US12/178,180
• Publication Number:
  US 20100023115A1
• Time in Patent Office: 1,042 Days
• Field of Search: 623/1.15, 623/1.39, 623/1.42, 623/1.44, 623/1.46
• US Class Current: 623/1.42
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2230/0054 V-shaped
• CPC Class Codes: A61F 2250/0036 differing in thickness
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir

Abstract

A stent for delivering therapeutic agents to a body lumen includes a plurality of circumferential serpentine bands with each band comprising a plurality of struts. At least one strut has at least one first well region and at least one second well region. The at least one first well region has a first thickness, the at least one second well region has a second thickness, the first thickness being greater than the second thickness. Each well region defines a well having a depth. At least some of the wells contain a therapeutic agent.

Claims

1. A stent for delivering therapeutic agents to a body lumen, the stent comprising:

a plurality of circumferential serpentine bands, each band comprising a plurality of struts, each strut having an outer surface, an inner surface, and a strut thickness between the outer surface and the inner surface, the strut thickness being variable along at least a portion of a length of the strut, at least one strut located on the strut at at least one first well region and at least one second well region, the at least one first well region located on the strut at a first strut thickness, the at least one second well region having a second strut thickness, the first strut thickness being greater than the second strut thickness, each well region defining at least one well, each well having a depth extending from the outer surface of the strut through at least a portion of the strut thickness, at least some of the wells containing a therapeutic agent.

2. The stent of claim 1, wherein each well has a volume, the at least one well defined by the at least one first well region having a first volume, the at least one well defined by the at least one second well region having a second volume, the first volume being greater than the second volume.

3. The stent of claim 1, wherein at least one second well region is positioned between two first well regions.

4. The stent of claim 1, wherein the depth of at least one of the wells extends completely through the strut thickness.

5. The stent of claim 1, wherein the well region comprises a durable coating, the durable coating being immediately adjacent and at least partially defining at least one well.

6. The stent of claim 1, wherein the strut further comprises a width, and wherein at least one of the first thickness and the second thickness have a ratio to the strut width of 1:

2.

7. The stent of claim 1, wherein the strut further comprises a width, and wherein at least one of the first thickness and the second thickness have a ratio to the strut width of 2:

1.